Biocon Biologics, Viatris to offer Insulin Glargine by Walgreens Prescription Savings Club
Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. have confirmed that Insulin Glargine (insulin glargine-yfgn) injection will be offered through the Walgreens Prescription Savings Club, saving members up to 80 percent off the cash price of comparable long-acting insulins purchased at Walgreens.
This decision by Walgreens follows the launch of Insulin Glargine (insulin glargine-yfgn) announced on November 16.
"Biocon Biologics and Viatris co-developed the product, and together the companies are committed to improving patients' access to sustainable, quality and more affordable healthcare," the company said in a .
"The collaboration with Walgreens underscores our efforts to improve outcomes and access for patients by meeting the needs of cash-paying patients and partnering with key stakeholders across the country to lower out-of-pocket costs for insulin users," Biocon added.
Read also: Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids
